These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20537544)

  • 1. Discovery of tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin KSP.
    Liu F; Yu LQ; Jiang C; Yang L; Wu WT; You QD
    Bioorg Med Chem; 2010 Jun; 18(12):4167-77. PubMed ID: 20537544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
    Ruan XQ; Chen M; Wu WT; You QD
    Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of new tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin Eg5.
    Sunder-Plassmann N; Sarli V; Gartner M; Utz M; Seiler J; Huemmer S; Mayer TU; Surrey T; Giannis A
    Bioorg Med Chem; 2005 Nov; 13(22):6094-111. PubMed ID: 16084101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis and biological evaluation of tetrahydro-beta-carline derivatives].
    Ruan XQ; You QD; Yang L; Wu WT
    Yao Xue Xue Bao; 2008 Aug; 43(8):828-32. PubMed ID: 18956775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors.
    Takeuchi T; Oishi S; Watanabe T; Ohno H; Sawada J; Matsuno K; Asai A; Asada N; Kitaura K; Fujii N
    J Med Chem; 2011 Jul; 54(13):4839-46. PubMed ID: 21599002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors.
    Dong JJ; Li QS; Liu ZP; Wang SF; Zhao MY; Yang YH; Wang XM; Zhu HL
    Eur J Med Chem; 2013; 70():427-33. PubMed ID: 24184776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.
    Barsanti PA; Wang W; Ni ZJ; Duhl D; Brammeier N; Martin E; Bussiere D; Walter AO
    Bioorg Med Chem Lett; 2010 Jan; 20(1):157-60. PubMed ID: 19945875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, anticancer screening, docking studies and in silico ADME prediction of some β-carboline derivatives.
    Abdelsalam MA; AboulWafa OM; M Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N; Elaasser MM
    Future Med Chem; 2018 May; 10(10):1159-1175. PubMed ID: 29787297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo design, synthesis and biological evaluation of 1,4-dihydroquinolin-4-ones and 1,2,3,4-tetrahydroquinazolin-4-ones as potent kinesin spindle protein (KSP) inhibitors.
    Jiang C; Yang L; Wu WT; Guo QL; You QD
    Bioorg Med Chem; 2011 Sep; 19(18):5612-27. PubMed ID: 21856161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors.
    Mansoor UF; Angeles AR; Dai C; Yang L; Vitharana D; Basso AD; Gray K; Tang H; Liu M; Liang L; Allbritton O; Siddiqui MA
    Bioorg Med Chem; 2015 May; 23(10):2424-34. PubMed ID: 25868746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells.
    Marcus AI; Peters U; Thomas SL; Garrett S; Zelnak A; Kapoor TM; Giannakakou P
    J Biol Chem; 2005 Mar; 280(12):11569-77. PubMed ID: 15653676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of some β-carboline derivatives as multi-target anticancer agents.
    Abdelsalam MA; AboulWafa OM; Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N
    Future Med Chem; 2018 Dec; 10(24):2791-2814. PubMed ID: 30539666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a kinesin inhibitor.
    Sakowicz R; Finer JT; Beraud C; Crompton A; Lewis E; Fritsch A; Lee Y; Mak J; Moody R; Turincio R; Chabala JC; Gonzales P; Roth S; Weitman S; Wood KW
    Cancer Res; 2004 May; 64(9):3276-80. PubMed ID: 15126370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP.
    Cox CD; Breslin MJ; Mariano BJ; Coleman PJ; Buser CA; Walsh ES; Hamilton K; Huber HE; Kohl NE; Torrent M; Yan Y; Kuo LC; Hartman GD
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2041-5. PubMed ID: 15808464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-ligand interaction-based virtual screening for novel Eg5/kinesin spindle protein inhibitors.
    Nagarajan S; Skoufias DA; Kozielski F; Pae AN
    J Med Chem; 2012 Mar; 55(6):2561-73. PubMed ID: 22309208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress on kinesin spindle protein inhibitors as anti-cancer agents.
    Zhang Y; Xu W
    Anticancer Agents Med Chem; 2008 Aug; 8(6):698-704. PubMed ID: 18690830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ATP-competitive kinesin spindle protein inhibitors.
    Parrish CA; Adams ND; Auger KR; Burgess JL; Carson JD; Chaudhari AM; Copeland RA; Diamond MA; Donatelli CA; Duffy KJ; Faucette LF; Finer JT; Huffman WF; Hugger ED; Jackson JR; Knight SD; Luo L; Moore ML; Newlander KA; Ridgers LH; Sakowicz R; Shaw AN; Sung CM; Sutton D; Wood KW; Zhang SY; Zimmerman MN; Dhanak D
    J Med Chem; 2007 Oct; 50(20):4939-52. PubMed ID: 17725339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and anticancer evaluation of tetrahydro-β-carboline-hydantoin hybrids.
    Shankaraiah N; Nekkanti S; Chudasama KJ; Senwar KR; Sharma P; Jeengar MK; Naidu VG; Srinivasulu V; Srinivasulu G; Kamal A
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5413-7. PubMed ID: 25453799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
    Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
    Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
    Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.